- Home
- PRPO vs MULN Comparison
PRPO vs MULN Comparison
Compare PRPO & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- MULN
- Stock Information
- Founded
- PRPO N/A
- MULN 2014
- Country
- PRPO United States
- MULN United States
- Employees
- PRPO N/A
- MULN N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- MULN Auto Manufacturing
- Sector
- PRPO Industrials
- MULN Consumer Discretionary
- Exchange
- PRPO Nasdaq
- MULN Nasdaq
- Market Cap
- PRPO 12.3M
- MULN 12.2M
- IPO Year
- PRPO N/A
- MULN N/A
- Fundamental
- Price
- PRPO $10.14
- MULN $4.01
- Analyst Decision
- PRPO
- MULN
- Analyst Count
- PRPO 0
- MULN 0
- Target Price
- PRPO N/A
- MULN N/A
- AVG Volume (30 Days)
- PRPO 13.1K
- MULN 510.8K
- Earning Date
- PRPO 03-28-2025
- MULN 02-19-2025
- Dividend Yield
- PRPO N/A
- MULN N/A
- EPS Growth
- PRPO N/A
- MULN N/A
- EPS
- PRPO N/A
- MULN N/A
- Revenue
- PRPO $17,411,000.00
- MULN $4,014,807.00
- Revenue This Year
- PRPO $75.18
- MULN N/A
- Revenue Next Year
- PRPO N/A
- MULN N/A
- P/E Ratio
- PRPO N/A
- MULN N/A
- Revenue Growth
- PRPO 31.31
- MULN 996.94
- 52 Week Low
- PRPO $4.31
- MULN $3.96
- 52 Week High
- PRPO $10.74
- MULN $47,100.00
- Technical
- Relative Strength Index (RSI)
- PRPO 85.00
- MULN 22.53
- Support Level
- PRPO $7.02
- MULN $10.80
- Resistance Level
- PRPO $7.54
- MULN $21.00
- Average True Range (ATR)
- PRPO 0.50
- MULN 2.78
- MACD
- PRPO 0.29
- MULN 1.42
- Stochastic Oscillator
- PRPO 85.72
- MULN 0.29
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and building energy solutions. Its portfolio of vehicles is predominantly comprised of commercial trucks and other electric vehicles and includes; Mullen Class 1 Cargo Van, Mullen Three, Bollinger B4 Chassis Cab, and Mullen I-GO. The company's operating segments are Bollinger which derives maximum revenue, and Mullen Commercial.